Altamira Therapeutics Ltd. (CYTO)
NASDAQ: CYTO · IEX Real-Time Price · USD
1.200
-0.140 (-10.45%)
At close: Jul 19, 2024, 4:00 PM
1.140
-0.060 (-5.00%)
Pre-market: Jul 22, 2024, 9:03 AM EDT
Altamira Therapeutics Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
10
Market Cap
2.69M USD
Revenue Chart
* The company reports in CHF currency but revenue data is shown in USD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 0 | - | - |
Dec 31, 2022 | 0 | - | - |
Dec 31, 2021 | 0 | - | - |
Dec 31, 2020 | 0 | - | - |
Dec 31, 2019 | 0 | - | - |
Dec 31, 2018 | 0 | - | - |
Dec 31, 2017 | 0 | - | - |
Dec 31, 2016 | 0 | - | - |
Dec 31, 2015 | 0 | - | - |
Dec 31, 2014 | 0 | - | - |
Dec 31, 2013 | 0 | - | - |
Dec 31, 2012 | 0 | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionCYTO News
- 3 days ago - Altamira Therapeutics Announces Publication of Preclinical Data Showing Successful Treatment of Abdominal Aortic Aneurysm with SOD2 mRNA Delivered by SemaPhore Nanoparticles - GlobeNewsWire
- 4 weeks ago - Altamira Therapeutics Highlights Newly Published Review Article Supporting Use of Betahistine in Vertigo Management - GlobeNewsWire
- 7 weeks ago - Altamira Therapeutics Provides Business Update - GlobeNewsWire
- 2 months ago - Altamira Therapeutics Announces Dissemination of Positive Results from Bentrio Trial in Seasonal Allergic Rhinitis Through Social Media Channels of Top Allergy Journal - GlobeNewsWire
- 2 months ago - Altamira Therapeutics Announces Filing of Provisional Patent Application for OligoPhore Nanoparticles with siRNA Targeting p65 Protein in Treatment of Cancer and Inflammation - GlobeNewsWire
- 3 months ago - Altamira Therapeutics Announces Publication of Positive Results from Bentrio Trial in Seasonal Allergic Rhinitis in Top Peer Reviewed Journal - GlobeNewsWire
- 3 months ago - Altamira Therapeutics to Host Full Year 2023 Financial Results and Business Update Call on April 10, 2024 - GlobeNewsWire
- 4 months ago - Altamira Therapeutics Announces Collaboration with Univercells Group on Nanoparticle-Delivered mRNA Vaccines - GlobeNewsWire